Concepedia

Ifosfamide and Vinorelbine in Advanced Platinum-Resistant Ovarian Cancer: Excessive Toxicity with a Potentially Active Regimen

Antonio González-Martı́n, Carmen Crespo, José Luis Garcı́a-López, Manuela Pedraza, Pilar Garrido, Enrique Lastra, A Moyano

Gynecologic Oncology · 2002 · 17 citations · 15 references

DOI

Concepts

References

15

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

, , +16

Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials

John Bryant, Roger Day · Biometrics · 1995 · 261 citations

, , +14

Prediction of Ifosfamide/Mesna associated encephalopathy

C. A. Meanwell, Alison E. Blake, Krystyna A. Kelly et al. · European Journal of Cancer and Clinical Oncology · 1986 · 151 citations

, , +4

Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease.

Emilio Bajetta, Angelo Di Leo, Laura Biganzoli et al. · Journal of Clinical Oncology · 1996 · 140 citations

, , +15

Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.

M Markman, Thomas B. Hakes, Bonnie Reichman et al. · Journal of Clinical Oncology · 1992 · 135 citations

, , +15